Literature DB >> 30788168

Multimodality management of incidentally detected gall bladder cancer: long term results from a tertiary care cancer centre.

Sunil Kumar1, Sandeep Bhoriwal1, Dillip Muduly2, Madhabananda Kar2, Atul Sharma3, Sushmita Pathy4, Nootan Kumar Shukla1, S V Suryanarayana Deo1.   

Abstract

BACKGROUND: Gall bladder cancer (GBC) is the most common biliary tract malignancy in India. GBC present either with incidental diagnosis after simple cholecystectomy (SC) or with a primary gall bladder mass. Incidentally detected gall bladder cancer (ICGB) has traditionally been thought to be a relatively early stage disease but there are controversies associated with various aspects of its management. In this article we describe our experience with multimodality management of ICGB.
METHODS: A retrospective analysis of incidentally detected GBC patients was performed to analyze the profile of presentation and treatment outcome. After initial radiological evaluation for operability, all the patients underwent surgical exploration. If found resectable, revision surgery including 2 cm wedge resection of liver and lymphadenectomy was done followed by concurrent chemo-radiation for tumors T2 and above stages.
RESULTS: A total of 54 patients with incidentally detected GBC with a male to female ratio of 1:3 and mean age of 47.5 years were included in the study. Thirty-four (63%) patients underwent curative resection followed by adjuvant chemoradiotherapy. The remaining 20 patients had metastatic/unresectable disease. The 5 years disease free and overall survival (OS) for patients receiving curative treatment was 64% and 72% respectively. On univariate analysis, presence of residual disease in the gallbladder fossa and liver were significant risk factors for disease recurrence. Depth of invasion, adjuvant treatment received and stage were significant prognostic factors for OS.
CONCLUSIONS: Incidentally detected GBC is increasing in incidence. A multi-modality approach with revision surgery and adjuvant chemo-radiation treatment may yield better outcome. Presence of residual disease is a poor prognostic factor. Optimal evaluation before SC and early referral to specialty center is therefore important in patients with suspicion of gallbladder malignancy because first chance is probably the best chance.

Entities:  

Keywords:  Multi-modality therapy; carcinoma gall bladder; incidentally detected gall bladder cancer (IGBC)

Year:  2019        PMID: 30788168      PMCID: PMC6351296          DOI: 10.21037/jgo.2018.09.10

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  28 in total

1.  Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention.

Authors:  Y Fong; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

2.  Gallbladder cancer in Chile. A report on 54 potentially resectable tumors.

Authors:  X de Aretxabala; I Roa; L Burgos; J C Araya; L Fonseca; I Wistuba; P Flores
Journal:  Cancer       Date:  1992-01-01       Impact factor: 6.860

3.  Radical surgery for gallbladder cancer: a worthwhile operation?

Authors:  A Muratore; R Polastri; H Bouzari; V Vergara; L Capussotti
Journal:  Eur J Surg Oncol       Date:  2000-03       Impact factor: 4.424

4.  Unsuspected gallbladder carcinoma after laparoscopic cholecystectomy.

Authors:  Hideo Yamamoto; Naokazu Hayakawa; Yuji Kitagawa; Yuki Katohno; Takahiro Sasaya; Daisuke Takara; Masato Nagino; Yuji Nimura
Journal:  J Hepatobiliary Pancreat Surg       Date:  2005

5.  Completion radical surgery after cholecystectomy for accidentally undiagnosed gallbladder carcinoma.

Authors:  Takayuki Toyonaga; Kazuo Chijiiwa; Kenji Nakano; Hirokazu Noshiro; Koji Yamaguchi; Masayuki Sada; Reiji Terasaka; Kohki Konomi; Fujihiko Nishikata; Masao Tanaka
Journal:  World J Surg       Date:  2003-02-27       Impact factor: 3.352

6.  Radical operations for carcinoma of the gallbladder: present status in Japan.

Authors:  Y Ogura; R Mizumoto; S Isaji; T Kusuda; S Matsuda; M Tabata
Journal:  World J Surg       Date:  1991 May-Jun       Impact factor: 3.352

7.  Actual recurrence patterns and risk factors influencing recurrence after curative resection with stage II gallbladder carcinoma.

Authors:  Joon Seong Park; Dong Sup Yoon; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee; Hoon Sang Chi; Byong Ro Kim
Journal:  J Gastrointest Surg       Date:  2007-05       Impact factor: 3.452

8.  What is an adequate extent of resection for T1 gallbladder cancers?

Authors:  Dong Do You; Hyung Geun Lee; Kwang Yeol Paik; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi
Journal:  Ann Surg       Date:  2008-05       Impact factor: 12.969

9.  Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.

Authors:  William R Jarnagin; Leyo Ruo; Sarah A Little; David Klimstra; Michael D'Angelica; Ronald P DeMatteo; Raquel Wagman; Leslie H Blumgart; Yuman Fong
Journal:  Cancer       Date:  2003-10-15       Impact factor: 6.860

10.  Immediate re-resection of T1 incidental gallbladder carcinomas: a survival analysis of the German Registry.

Authors:  T O Goetze; V Paolucci
Journal:  Surg Endosc       Date:  2008-02-05       Impact factor: 4.584

View more
  1 in total

1.  Limits of serum carcinoembryonic antigen and carbohydrate antigen 19-9 as the diagnosis of gallbladder cancer.

Authors:  Jae Seung Kang; Su Young Hong; Youngmin Han; Hee Ju Sohn; Mirang Lee; Yoon Hyung Kang; Hyeong Seok Kim; Hongbeom Kim; Wooil Kwon; Jin-Young Jang
Journal:  Ann Surg Treat Res       Date:  2021-10-29       Impact factor: 1.859

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.